Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Wet Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01016873
What this trial is testing

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

Who this might be right for
AMDWet AMDAge-Related Macular Degeneration+4 more
Oraya Therapeutics, Inc. 230
Not applicableNot Yet RecruitingNCT05780931
What this trial is testing

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
VA Office of Research and Development 20
Not applicableStudy completedNCT04137120
What this trial is testing

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Who this might be right for
Retinal Disease
Bayer 73
Testing effectiveness (Phase 2)Study completedNCT00239928
What this trial is testing

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 61
Large-scale testing (Phase 3)Study completedNCT01748292
What this trial is testing

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab

Who this might be right for
Macular Degeneration
Charles C Wykoff, PhD, MD 60
Not applicableLooking for participantsNCT02253030
What this trial is testing

OCT Angiography in Wet AMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Oregon Health and Science University 160
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Testing effectiveness (Phase 2)UnknownNCT01249937
What this trial is testing

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Who this might be right for
Wet Macular Degeneration
University Health Network, Toronto 30
Testing effectiveness (Phase 2)UnknownNCT02749734
What this trial is testing

Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases

Who this might be right for
Macular DegenerationStargardt's Macular Dystrophy
Southwest Hospital, China 15
Not applicableStudy completedNCT05211804
What this trial is testing

Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse

Who this might be right for
Wet Macular Degeneration
Sorlandet Hospital HF 31
Not applicableWithdrawnNCT01336907
What this trial is testing

Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Notal Vision Ltd.
Not applicableLooking for participantsNCT06718816
What this trial is testing

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 21
Early research (Phase 1)Study completedNCT00722384
What this trial is testing

Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5

Who this might be right for
Macular Degeneration
OPKO Health, Inc. 15
Early research (Phase 1)Study completedNCT02061865
What this trial is testing

Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD

Who this might be right for
Neovascular Wet Age-related Macular Degeneration (AMD)
Regeneron Pharmaceuticals 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07766473
What this trial is testing

First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Filamon LTD 24
Testing effectiveness (Phase 2)Ended earlyNCT00766337
What this trial is testing

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Santen Inc. 62
Testing effectiveness (Phase 2)Study completedNCT06704009
What this trial is testing

NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

Who this might be right for
Wet Age Related Macular DegenerationWet AMD
NexThera Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT02355028
What this trial is testing

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon, a Novartis Company 136
Next Page